volume 27, issue 6, P523-526 2006
DOI: 10.2500/aap.2006.27.2897
View full text
|
Sign up to set email alerts
|
Share

Abstract: Several trials have indicated that topical tacrolimus is safe and effective for several immunologic-based skin disorders. We report a child <2 months old, who was admitted to our pediatric department because of generalized erythroderma. We started tacrolimus ointment 0.03% therapy by applying the ointment to the skin once daily, on a limited surface of 10 cm(2), changing the skin areas only after the disappearance of inflammation. After only one application we observed a marked improvement of the treated area …

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

0
0
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals